Gastric sleeve surgery is one of the most widely performed bariatric procedures in the UK, offering a clinically proven approach to achieving sustained weight loss in people living with obesity. Formally known as sleeve gastrectomy, the operation permanently reduces stomach size, limiting food intake and altering hunger-regulating hormones. Available through both NHS and private pathways, it is recognised by NICE as an effective intervention for eligible patients. This article covers how the procedure works, who qualifies, what to expect before and after surgery, potential risks, and the long-term dietary and lifestyle changes essential for lasting success.

What Is Gastric Sleeve Surgery and How Does It Work

Gastric sleeve surgery removes 75–80% of the stomach laparoscopically, restricting food intake and reducing ghrelin production to suppress appetite and support weight loss. Lifelong nutritional monitoring is essential despite the digestive tract not being rerouted.

Have any more questions about this? Message our pharmaceutical team to get more info →

Gastric sleeve surgery, formally known as sleeve gastrectomy, is a type of bariatric (weight-loss) surgical procedure in which approximately 75–80% of the stomach is permanently removed, leaving a narrow, tube-shaped 'sleeve' roughly the size and shape of a banana. This significantly reduces the stomach's capacity, meaning patients feel full much sooner after eating smaller portions.

The procedure works through several mechanisms:

• Restriction: The reduced stomach volume limits the amount of food that can be consumed at any one time.

• Hormonal and metabolic changes: Removing a large portion of the stomach reduces production of ghrelin, a hormone largely responsible for stimulating hunger, helping to suppress appetite. The procedure also produces broader metabolic effects, including changes to incretin hormones such as GLP-1, which contribute to improvements in blood glucose regulation and metabolic health beyond weight loss alone.

It is important to note that, although the digestive tract is not rerouted, the significant reduction in food intake and altered gastric physiology following sleeve gastrectomy can still lead to deficiencies in key micronutrients, including vitamin B12, iron, vitamin D, calcium, and folate. Lifelong nutritional monitoring and supplementation are therefore essential.

Gastric sleeve surgery is performed laparoscopically (keyhole surgery) under general anaesthesia, typically taking between 60 and 90 minutes. In the UK, sleeve gastrectomy has become one of the most commonly performed bariatric procedures, favoured for its relative simplicity compared to bypass techniques and its strong evidence base for achieving sustained weight loss. It is offered through both NHS pathways and private providers, and is recognised by NICE (CG189) as an effective intervention for eligible patients with obesity.

Who Is Eligible for Gastric Sleeve Surgery in the UK

NICE CG189 criteria require a BMI of 40 kg/m² or above, or 35–39.9 kg/m² with a significant comorbidity, after non-surgical interventions have been tried. NHS access follows a structured Tier 3 to Tier 4 pathway via GP referral.

Eligibility for gastric sleeve surgery in the UK is guided primarily by NICE Clinical Guideline CG189 (Obesity: identification, assessment and management) and NICE Guideline NG28 (Type 2 diabetes in adults: management), which set out clear criteria for referral to specialist bariatric services.

NICE eligibility criteria typically include:

• A Body Mass Index (BMI) of 40 kg/m² or above, or

• A BMI of 35–39.9 kg/m² with a significant obesity-related comorbidity such as type 2 diabetes, hypertension, obstructive sleep apnoea, or joint disease

• In some cases, individuals with a BMI of 30–34.9 kg/m² may be considered if they have recent-onset type 2 diabetes, particularly within a structured programme

• For people of South Asian family origin, NICE advises that BMI thresholds should be reduced by 2.5 kg/m², reflecting the higher metabolic risk at lower BMI in this population

• People with a BMI of 35 kg/m² or above and recent-onset type 2 diabetes (diagnosed within the last 10 years) should be offered an expedited assessment for bariatric surgery, as per NICE NG28

• Demonstration that non-surgical weight management interventions (dietary changes, physical activity, behavioural support, pharmacotherapy) have been tried and have not achieved or maintained adequate weight loss

• Fitness for general anaesthesia and surgery, assessed through a multidisciplinary team (MDT)

• Commitment to long-term dietary and lifestyle changes, including attendance at follow-up appointments

NHS referral pathway: In England, NHS access to bariatric surgery typically follows a structured pathway. Patients are usually referred through Tier 3 specialist weight management services (community-based, intensive lifestyle and medical support) before progressing to Tier 4 bariatric surgical services. A GP referral is the usual starting point. Waiting times can be lengthy, and provision varies by Integrated Care Board (ICB) area.

Patients are also assessed for psychological readiness, as bariatric surgery requires significant behavioural adjustment. Contraindications may include untreated severe mental health conditions, active substance misuse, or certain medical conditions that increase surgical risk.

Many patients in the UK choose to access surgery through private providers, where the same clinical eligibility principles generally apply. A thorough pre-operative assessment by an appropriately qualified MDT remains essential regardless of the funding route.

What to Expect Before, During and After the Procedure

Patients undergo a pre-operative MDT assessment, a 2–4 week liver-shrinking diet, and staged dietary progression from clear fluids to solid foods over approximately six weeks post-surgery. Most people return to light activities within 2–4 weeks.

Preparation for gastric sleeve surgery is a structured process that begins well before the operating theatre. Patients referred through NHS or private pathways will typically undergo a comprehensive pre-operative assessment involving a multidisciplinary team including a bariatric surgeon, dietitian, psychologist, and specialist nurse.

Before surgery, patients can expect:

• Blood tests, cardiovascular assessment, and imaging where indicated

• A pre-operative liver-shrinking diet (usually a low-calorie or low-carbohydrate diet lasting 2–4 weeks) to reduce liver size and improve surgical access

• Nutritional counselling and education on post-operative dietary requirements

• Review and adjustment of medications by the clinical team. Patients should not stop or alter any medication without clinical guidance. Of particular note, SGLT2 inhibitors (e.g., dapagliflozin, empagliflozin) should be withheld before major surgery due to the risk of euglycaemic diabetic ketoacidosis, in line with MHRA advice — the clinical team will advise on timing

• Smoking cessation is strongly recommended, as smoking significantly increases surgical and anaesthetic risk

• Patients should also be aware that NSAIDs (e.g., ibuprofen) are generally not recommended after bariatric surgery due to the risk of gastric irritation and ulceration

During the procedure, the surgeon uses laparoscopic instruments inserted through small incisions in the abdomen. The majority of the stomach is stapled and removed. Most patients are discharged within 1–3 days, depending on recovery.

Post-operative dietary progression follows a staged approach in line with British Obesity and Metabolic Surgery Society (BOMSS) guidance, though individual centres may vary slightly:

• Days 1–3: Clear fluids only (water, diluted squash, clear broth)

• Weeks 1–2: Smooth liquids (e.g., thinned soups, milk, protein shakes)

• Weeks 2–4: Pureed and very soft foods

• Weeks 4–6: Soft, moist foods

• Week 6 onwards: Gradual reintroduction of solid foods as tolerated

Patients should always follow the specific dietary guidance provided by their own bariatric team, as protocols may differ between centres.

A proton pump inhibitor (PPI) is typically prescribed in the early post-operative period to protect the gastric sleeve lining and reduce acid-related symptoms.

Fatigue, discomfort, and nausea are common in the early weeks. Most people can return to light activities within 2–4 weeks, with full recovery typically achieved within 4–6 weeks.

Follow-up and reproductive health: Patients should attend all scheduled follow-up appointments. Specialist MDT review is typically recommended for at least two years post-operatively, after which lifelong annual monitoring is coordinated through primary care. Women of childbearing age are advised to avoid pregnancy for at least 12–18 months following surgery, as rapid weight loss during this period can affect foetal development. Effective contraception should be discussed with a clinician before and after surgery; the Faculty of Sexual and Reproductive Healthcare (FSRH) provides specific guidance on contraceptive choices following bariatric procedures, as some oral contraceptives may be less reliably absorbed.

Risks, Complications and Long-Term Considerations

Short-term risks include staple line leak, bleeding, and DVT; longer-term concerns include worsening acid reflux, gallstones, nutritional deficiencies, and weight regain. Lifelong annual blood monitoring is recommended by BOMSS guidance.

As with any major surgical procedure, gastric sleeve surgery carries both short-term and long-term risks. Patients should receive thorough informed consent discussions with their surgical team prior to proceeding.

Short-term surgical risks include:

• Bleeding or haematoma formation

• Staple line leak (a serious but relatively uncommon complication occurring in approximately 1–3% of cases), which may require further intervention

• Stricture or narrowing of the sleeve, which may cause difficulty swallowing or persistent vomiting

• Infection, including wound infection or intra-abdominal abscess

• Deep vein thrombosis (DVT) or pulmonary embolism — patients are given prophylactic anticoagulation and compression stockings to reduce this risk

• Dehydration, particularly in the early post-operative period

• Adverse reactions to anaesthesia

Longer-term considerations include:

• Gastro-oesophageal reflux disease (GORD): A significant proportion of patients experience worsening or new-onset acid reflux following sleeve gastrectomy. Patients with significant pre-existing reflux symptoms should discuss this with their MDT, as an alternative procedure (such as gastric bypass) may be more appropriate in some cases

• Gallstones: Rapid weight loss increases the risk of gallstone formation. Patients should be aware of symptoms such as right upper abdominal pain, particularly after eating

• Nutritional deficiencies: Reduced food intake can lead to deficiencies in vitamin B12, iron, vitamin D, calcium, and folate. Lifelong supplementation and regular blood monitoring are essential (see below)

• Weight regain: Some patients experience weight regain after 2–5 years, particularly if dietary and lifestyle changes are not maintained

• Psychological adjustment: Changes in body image, eating habits, and social dynamics around food can be challenging; ongoing psychological support is beneficial

Lifelong nutritional monitoring: BOMSS guidance recommends regular blood tests to monitor nutritional status. These typically include full blood count (FBC), ferritin, folate, vitamin B12, vitamin D, and calcium/PTH, checked at defined intervals post-operatively and then at least annually thereafter. After discharge from specialist care, this monitoring is usually coordinated by the patient's GP.

When to seek urgent help: Patients should call 999 or attend A&E immediately if they experience severe chest pain, sudden breathlessness, fainting, rapid heart rate with fever, or signs of DVT (leg swelling, redness, or pain). These may indicate serious complications such as pulmonary embolism or a staple line leak. For other concerns — including persistent vomiting, worsening abdominal pain, signs of wound infection, or symptoms suggestive of nutritional deficiency (such as fatigue, hair loss, or tingling in the extremities) — patients should contact NHS 111, their GP, or their bariatric team promptly.

If you experience a suspected side effect related to a medicine or medical device, you can report this via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

Life After Gastric Sleeve Surgery: Diet and Lifestyle Advice

Long-term success requires small frequent meals, high protein intake, lifelong vitamin and mineral supplementation, and regular physical activity. Ongoing annual blood monitoring through primary care and avoidance of NSAIDs and alcohol are strongly advised.

Long-term success following gastric sleeve surgery depends heavily on sustained dietary and lifestyle changes. Surgery is a tool, not a cure — and the habits developed in the months and years following the procedure are critical to achieving and maintaining a healthy weight.

Dietary principles post-surgery include:

• Eat small, frequent meals: The reduced stomach capacity means large meals are not tolerable. Aim for 4–6 small meals per day

• Prioritise protein: Protein should be the focus of every meal to preserve muscle mass and support healing. Most bariatric dietitians recommend a target of approximately 60–80 g of protein per day, though individual targets should be confirmed with your dietitian. Good sources include lean meat, fish, eggs, dairy, and legumes

• Avoid high-sugar and high-fat foods: These can cause discomfort and contribute to weight regain

• Chew thoroughly and eat slowly: Eating too quickly can cause nausea, vomiting, or discomfort. Avoid grazing between meals, as this can undermine weight loss

• Separate fluids from meals: Drinking during meals can cause the sleeve to fill too quickly; aim to drink fluids at least 30 minutes before or after eating

• Stay well hydrated: Aim for at least 1.5–2 litres of fluid daily, predominantly water. Avoid carbonated and caffeinated drinks, particularly in the early post-operative period

• Avoid alcohol: Alcohol is absorbed more rapidly after bariatric surgery and carries a higher risk of dependency; it should be avoided or kept to a minimum

• Avoid NSAIDs (e.g., ibuprofen) where possible, due to the risk of gastric ulceration in the sleeve

Lifelong supplementation: In line with BOMSS guidance, most patients will require lifelong vitamin and mineral supplementation. A typical regimen includes:

• A complete bariatric multivitamin and mineral supplement (providing iron, zinc, selenium, and other micronutrients)

• Calcium and vitamin D (usually as calcium citrate with vitamin D3, as calcium carbonate is less well absorbed post-sleeve)

• Vitamin B12 — either as intramuscular injections or high-dose oral supplementation, as absorption may be reduced

• Iron supplementation, particularly for women of childbearing age

• Thiamine (vitamin B1) supplementation may be recommended if prolonged vomiting occurs

The specific regimen should be agreed with your bariatric dietitian and reviewed regularly. Do not self-prescribe supplements without clinical guidance.

Physical activity should be gradually reintroduced following surgical clearance. Regular exercise — including both cardiovascular and resistance training — supports weight maintenance, improves metabolic health, and enhances psychological wellbeing.

Lifelong follow-up: After the initial period of specialist MDT review (typically at least two years), ongoing annual blood monitoring is coordinated through primary care. Patients are strongly encouraged to attend these appointments and to seek support from their GP, dietitian, or bariatric team if they have concerns at any stage. Support groups, both in-person and online, can also provide valuable peer support.

With the right commitment to dietary, lifestyle, and medical follow-up, gastric sleeve surgery can be a highly effective long-term intervention for improving health and quality of life.

Frequently Asked Questions